L.-D. Leder

560 total citations
29 papers, 322 citations indexed

About

L.-D. Leder is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, L.-D. Leder has authored 29 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in L.-D. Leder's work include Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). L.-D. Leder is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). L.-D. Leder collaborates with scholars based in Germany. L.-D. Leder's co-authors include K. Metz, Ulrich Schmidt, K. Lennert, H. L�ffler, K Donhuijsen, C. Streffer, R. Fischer, N. Niederle, Hans Michael Kvasnicka and Stephan Schulz and has published in prestigious journals such as Cancer, British Journal of Cancer and The Journal of Pathology.

In The Last Decade

L.-D. Leder

27 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.-D. Leder Germany 12 85 74 65 62 55 29 322
Shinkichi Yokoyama Japan 11 108 1.3× 111 1.5× 48 0.7× 32 0.5× 61 1.1× 22 371
Antonio Acquaviva Italy 12 165 1.9× 60 0.8× 150 2.3× 56 0.9× 34 0.6× 38 457
Anne‐Marie Manel France 10 54 0.6× 141 1.9× 78 1.2× 54 0.9× 56 1.0× 21 333
Deborah Borek United States 9 34 0.4× 66 0.9× 101 1.6× 56 0.9× 140 2.5× 12 368
J.-O. Bay France 10 78 0.9× 122 1.6× 138 2.1× 36 0.6× 82 1.5× 24 370
R. Tubbs United States 9 99 1.2× 36 0.5× 115 1.8× 50 0.8× 118 2.1× 13 333
Ivan P. Law United States 10 48 0.6× 82 1.1× 96 1.5× 109 1.8× 45 0.8× 15 342
Henry Rappaport United States 6 38 0.4× 130 1.8× 76 1.2× 78 1.3× 35 0.6× 8 354
Françoise Delacrétaz Switzerland 9 110 1.3× 92 1.2× 107 1.6× 120 1.9× 45 0.8× 11 383
I‐Ting Yu Taiwan 12 91 1.1× 27 0.4× 113 1.7× 42 0.7× 82 1.5× 23 352

Countries citing papers authored by L.-D. Leder

Since Specialization
Citations

This map shows the geographic impact of L.-D. Leder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.-D. Leder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.-D. Leder more than expected).

Fields of papers citing papers by L.-D. Leder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.-D. Leder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.-D. Leder. The network helps show where L.-D. Leder may publish in the future.

Co-authorship network of co-authors of L.-D. Leder

This figure shows the co-authorship network connecting the top 25 collaborators of L.-D. Leder. A scholar is included among the top collaborators of L.-D. Leder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.-D. Leder. L.-D. Leder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donhuijsen, K & L.-D. Leder. (2008). Zellkerngrößen bei Non-Hodgkin-Lymphomen: Prognostische und diagnostische Bedeutung. DMW - Deutsche Medizinische Wochenschrift. 110(31/32). 1206–1211.
2.
Thiele, Jüergen, Thomas K. Zirbes, Johann Lorenzen, et al.. (1997). Apoptosis and proliferation (PCNA labelling) in CML—a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy. The Journal of Pathology. 181(3). 316–322. 24 indexed citations
3.
4.
Thiele, Jüergen, T. K. Zirbes, H. M. Kvasnicka, et al.. (1996). Effect of Interferon Therapy on Bone Marrow Morphology in Chronic Myeloid Leukemia: A Cytochemical and Immunohistochemical Study of Trephine Biopsies. Journal of Interferon & Cytokine Research. 16(3). 217–224. 6 indexed citations
5.
Schmidt, Ulrich, Jonathon Herbst, K. Metz, & L.-D. Leder. (1996). HOW TO DIFFERENTIATE BETWEEN T-CELL-RICH B-CELL LYMPHOMA AND LYMPHOCYTE-PREDOMINANT HODGKIN'S DISEASE. EVIDENCE FOR THE VALUE OF MB1 AND 4KB5 IMMUNOSTAINING. The Journal of Pathology. 179(2). 138–144. 10 indexed citations
6.
Schmidt, Ulrich & L.-D. Leder. (1996). T-Cell-Rich B-Cell Lymphoma - A Distinct Clinicopathologic Entity?. Leukemia & lymphoma. 23(1-2). 17–24. 10 indexed citations
7.
Thiele, J., Hans Michael Kvasnicka, N. Niederle, et al.. (1995). The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML — A comparative morphometric study on sequential trephine biopsies. Annals of Hematology. 70(3). 121–128. 17 indexed citations
8.
Thiele, Jüergen, Hans Michael Kvasnicka, N. Niederle, et al.. (1995). Clinical and histological features retain their prognostic impact under interferon therapy of CML: A pilot study. American Journal of Hematology. 50(1). 30–39. 10 indexed citations
9.
Schmidt, Ulrich, et al.. (1994). Well-differentiated (oncocytoid) neuroendocrine carcinoma of the larynx with multiple skin metastases: a brief report. The Journal of Laryngology & Otology. 108(3). 272–274. 20 indexed citations
10.
Donhuijsen, K, Stephan Schulz, & L.-D. Leder. (1991). Nuclear grading of renal cell carcinomas — is morphometry necessary?. Journal of Cancer Research and Clinical Oncology. 117(1). 73–78. 18 indexed citations
11.
Breuer, N., et al.. (1988). Large Bowel Cancer Risk in Cholelithiasis and after Cholecystectomy. Digestion. 40(4). 219–226. 21 indexed citations
12.
Donhuijsen, K, K. Metz, & L.-D. Leder. (1988). [Desmin and S 100 protein-positive malignant fibrous histiocytomas: practical and theoretical implications].. PubMed. 9(5). 261–7. 6 indexed citations
13.
Leder, L.-D.. (1986). [Individuality of malignant neoplasms].. PubMed. 162(10). 624–8. 1 indexed citations
14.
Metz, K., et al.. (1985). Adenocarcinoma of the colon with syncytiotrophoblastic differentiation: Differential diagnosis and implications. Pathology - Research and Practice. 179(3). 419–424. 20 indexed citations
15.
16.
Leder, L.-D. & K Donhuijsen. (1978). PAS-positive lymphatic cells in angioimmunoblastic lymphadenopathy. Journal of Molecular Medicine. 56(5). 225–227. 4 indexed citations
17.
Leder, L.-D.. (1978). Alkaline phosphatase and tartrate resistant acid phosphatase activity in cells of prolymphocytic leukemia. Journal of Molecular Medicine. 56(6). 313–314. 8 indexed citations
18.
Harms, D., et al.. (1975). Congenital Mesoblastic Nephroma of Infancy. Beiträge zur Pathologie. 154(1). 83–87. 5 indexed citations
19.
Leder, L.-D.. (1967). Die fermentcytochemische Erkennung normaler und neoplastischer Erythropoesezellen in Schnitt und Ausstrich. Annals of Hematology. 15(5). 289–293. 13 indexed citations
20.
Lennert, K., H. L�ffler, & L.-D. Leder. (1961). Fermenthistochemische Untersuchungen des Lymphknotens. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 334(5). 399–418. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinkichi Yokoyama Breakdown of academic impact, for papers by Antonio Acquaviva Breakdown of academic impact, for papers by Anne‐Marie Manel Breakdown of academic impact, for papers by Deborah Borek Breakdown of academic impact, for papers by J.-O. Bay Breakdown of academic impact, for papers by R. Tubbs Breakdown of academic impact, for papers by Ivan P. Law Breakdown of academic impact, for papers by Henry Rappaport Breakdown of academic impact, for papers by Françoise Delacrétaz Breakdown of academic impact, for papers by I‐Ting Yu
Rankless by CCL
2026